Oral prolonged-release Oxycodone-Naloxone: analgesic response, safety profile, and factors influencing the response in advanced cancer patients.
Corli O, Iorno V, Legramandi L, Rulli E, Roberto A, Azzarello G, Schiavon S, Cavanna L, De Santis S, Cartoni C, Di Marco P, Dauri M, Mistretta R, Bortolussi R, Clerico M, Pacchioni M, Crispino C, Marabese M, Corsi N; GREAT Collaborators.
Corli O, et al. Among authors: cartoni c.
Pain Pract. 2019 Mar 27. doi: 10.1111/papr.12784. Online ahead of print.
Pain Pract. 2019.
PMID: 30917409